Be the first to like this.
5 comment(s). Last comment by ThemePlay 2020-07-20 07:16
Posted by ThemePlay > 2020-06-17 02:14 | Report Abuse
Based on PE24, the target price will be $2.20
Posted by Goldberg > 2020-06-17 12:13 | Report Abuse
Strong Q3 result with Q3 EPS 20 Sen and 9 mth YTD EPS of 18.1 Sen
Valuation of RM2 to RM2.50 with PE range of 8 to 10.
Genetec is due for rerating given its improvement in top and bottom line in Q3 on securing new orders of RM38.5 mil for its new financial year ended 31 March 2021.
At 1.58 Sen, it is currently trading on historical PE 11.8 based on FY 2019 EPS of 13.82 Sen and forward PE 6.52 using a projected EPS 25 Sen for FY2020. Based on our projected FY 2020 EPS of 25 Sen ( 9 mth YTD EPS is 18.1 Sen) , using PE 8 to 12 would give GENETEC a valuation range of RM2.00 to RM2.50.
For 9 mth YTD FY 2020 the Co recorded a revenue of RM72 mil (9 mth YTD FY 2019 RM82.8 mil) and a net profit of RM7.3 mil (9 mth YTD FY 2019 RM9.7 mil) with an EPS of 18.1 Sen (FY 2019 23.45 Sen).
Note that in FY 2019, there was an impairment of RM5 mil goodwill written off in Q4 FY 2019 turning it into a net loss after tax of RM 3.7 mil for Q4 and FY 2019 result with a lower profit of RM6 mil with EPS 13.82 Sen
REVIEW OF PERFORMANCE
For the current quarter Q3 ended 31 December 2019, the Group recorded a revenue of RM40.1 million, an increase of 16.2% or RM5.6 million as compared to a revenue of RM34.5 million recorded in the preceding corresponding quarter ended 31 December 2018.
The Group recorded a net profit before tax of RM8.1 million (NPAT RM8.1 mil with EPS of 20 Sen) for the current quarter under review as compared to a net profit before tax of RM5.0 million (NPAT RM5.0 mil with EPS of 12.4 Sen) in the preceding corresponding quarter ended 31 December 2018.The increase in net profit before tax was mainly attributable to higher sales volume achieved and improved operational efficiency.
Posted by Xcalibre > 2020-06-25 10:44 | Report Abuse
WARRIOR TRADERS VIP OWNER & STAFF ... how much you still hold in Genetec since your buy call was made earlier when it was RM1.62?
Are you buying more now since lower price? How much more are you buying? You need to walk the talk.....
Looking forward to your reply here if you have the balls and also to give yourself the chance to clear your own bad reputation portrayed so far....
@Cheryl
Posted by ThemePlay > 2020-07-20 07:16 | Report Abuse
We invested based on our own risk appetite. We haven't gave up the company yet. Yes, we bought n average when people panic selling after the qr results. Qr already told u additional workforce hired to fulfil the orders. Why want to sell when the company have a lot of contract in hand?
No result.
2
Mercury Securities Research
3
Koon Yew Yin's Blog
5
6
THE INVESTMENT APPROACH OF CALVIN TAN
SUPERMAX VERSUS TOPGLOVE, KOSSAN & HARTA, Compare & Contrast, By Calvin Tan
7
8
#
Stock
Score
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mni75
114 posts
Posted by mni75 > 2020-06-16 16:04 | Report Abuse
Wow.. what tp for this